FUL poised for Q2 earnings with modest beat expectations and dividend rise
Jun 18, 2026, 8:42 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Positive consensus EPS and revenue growth, plus a dividend raise, may drive near-term upside around results; earnings beats historically trigger price gains, though misses can reverse quickly.
AI summary
What happened, with direct paths to the underlying reporting
H.B. Fuller reports Q2 results after the close on June 24. Analysts expect EPS of $1.38 on about $923.6 million in revenue, and the company recently raised the dividend by 4.3%. A solid print could prompt a short-term move toward the $65 level as investors weigh growth prospects and cash returns.
FUL to report Q2 results after close June 24; EPS seen at $1.38.
Revenue seen at $923.62M; up from $898.1M year ago.
Dividend up 4.3% on April 16; supports near-term yield.
Shares rose 1.7% to $64.77 on Wednesday.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
HB Fuller has offered to acquire AMS for £715 million in cash, expanding its medical adhesives platform and driving higher-margin growth. The deal widens HB Fuller’s total address…
H.B. Fuller has made an unsolicited offer to acquire Advanced Medical Solutions, which may enhance Fuller’s healthcare product offerings following a failed previous buyout. This s…
J.P. Morgan maintains Underweight rating on FUL, lowering forecast to $50. First-quarter revenue fell 2.7% to $789 million, organic growth up 1.9%. Health segment saw EBITDA drop…
H.B. Fuller will release Q1 results on March 26. Analysts predict earnings of 50 cents per share, down from 67 cents last year. Revenue for the quarter is projected at $769.11 mil…